Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening

NCT05043077 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity

Interventions

DRUG: Microdrop administration of phenylephrine 1.67% and tropicamide 0.33%
DRUG: Standard drop administration of phenylephrine 1.67% and tropicamide 0.33%

Sponsor

Aristotle University Of Thessaloniki

Collaborators

[object Object]